PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice

Research

Print page

Switch language

The Capital Region of Denmark - a part of Copenhagen University Hospital

Published

Research output: Contribution to journal › Journal article › Research › peer-review

Author

Kjaergaard, Marina ; Salinas, Casper Bo Gravesen ; Rehfeld, Jens F ; Secher, Anna ; Raun, Kirsten ; Wulff, Birgitte S. / PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice. In: Neuropeptides. 2019 ; Vol. 73. pp. 89-95.

Bibtex

@article{08d83fc40cb64164a640a7982e7e861d,

title = "PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice",

abstract = "Peptide YY(3-36) ((PYY(3-36)) and glucagon like peptide 1 (GLP-1) in combination reduce food intake and body weight in an additive or synergistic manner in animal models and in humans. Nevertheless, the mechanisms behind are not completely understood. The present study aims to investigate the effect of combining PYY(3-36) and the GLP-1 receptor agonist exendin-4 (Ex4) by examining acute food intake and global neuronal activation as measured by c-fos in C57BL/6 J mice. An additive reduction in food intake was found 1.5 h after s.c dosing with the combination of PYY(3-36) (200 μg/kg) and Ex4 (2.5 μg/kg). This was associated with a synergistic enhancement of c-fos reactivity in central amygdalar nucleus (CeA), rostral part of the mediobasal arcuate nucleus (ARH), supratrigeminal nucleus (SUT), lateral parabrachial nucleus (PB), area postrema (AP) and nucleus tractus solitarius (NTS) compared to vehicle, PYY(3-36) and Ex4 individually dosed mice. The regions activated by Ex4 individually and PYY(3-36) and Ex4 in combination resembled each other, but the combination group had a significantly stronger c-fos response. Twenty-five brain areas were activated by PYY(3-36) and Ex4 in combination compared to vehicle versus nine brain areas by Ex4 individually. No significant increase in c-fos reactivity was found by PYY(3-36) compared to vehicle dosed mice. The neuronal activation of ARH and the AP/NTS to PB to CeA pathway is important for appetite regulation while SUT has not previously been reported in the regulation of energy balance. As PYY(3-36) and Ex4 act on different neurons leading to recruitment of different signalling pathways within and to the brain, an interaction of these pathways may contribute to their additive/synergistic action. Thus, PYY(3-36) boosts the effect of Ex4 possibly by inducing less inhibition of neuronal activity leading to an enhanced neuronal activity induced by Ex4.",

keywords = "Amygdala/drug effects, Animals, Body Weight/drug effects, Eating/drug effects, Exenatide/pharmacology, Hypothalamus/drug effects, Mice, Neurons/drug effects, Peptide Fragments/pharmacology, Peptide YY/pharmacology, Proto-Oncogene Proteins c-fos/metabolism",

author = "Marina Kjaergaard and Salinas, {Casper Bo Gravesen} and Rehfeld, {Jens F} and Anna Secher and Kirsten Raun and Wulff, {Birgitte S}",

year = "2019",

month = "2",

doi = "10.1016/j.npep.2018.11.004",

language = "English",

volume = "73",

pages = "89--95",

journal = "Neuropeptides",

issn = "0143-4179",

publisher = "Churchill Livingstone",

}

RIS

TY - JOUR

T1 - PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice

AU - Kjaergaard, Marina

AU - Salinas, Casper Bo Gravesen

AU - Rehfeld, Jens F

AU - Secher, Anna

AU - Raun, Kirsten

AU - Wulff, Birgitte S

PY - 2019/2

Y1 - 2019/2

N2 - Peptide YY(3-36) ((PYY(3-36)) and glucagon like peptide 1 (GLP-1) in combination reduce food intake and body weight in an additive or synergistic manner in animal models and in humans. Nevertheless, the mechanisms behind are not completely understood. The present study aims to investigate the effect of combining PYY(3-36) and the GLP-1 receptor agonist exendin-4 (Ex4) by examining acute food intake and global neuronal activation as measured by c-fos in C57BL/6 J mice. An additive reduction in food intake was found 1.5 h after s.c dosing with the combination of PYY(3-36) (200 μg/kg) and Ex4 (2.5 μg/kg). This was associated with a synergistic enhancement of c-fos reactivity in central amygdalar nucleus (CeA), rostral part of the mediobasal arcuate nucleus (ARH), supratrigeminal nucleus (SUT), lateral parabrachial nucleus (PB), area postrema (AP) and nucleus tractus solitarius (NTS) compared to vehicle, PYY(3-36) and Ex4 individually dosed mice. The regions activated by Ex4 individually and PYY(3-36) and Ex4 in combination resembled each other, but the combination group had a significantly stronger c-fos response. Twenty-five brain areas were activated by PYY(3-36) and Ex4 in combination compared to vehicle versus nine brain areas by Ex4 individually. No significant increase in c-fos reactivity was found by PYY(3-36) compared to vehicle dosed mice. The neuronal activation of ARH and the AP/NTS to PB to CeA pathway is important for appetite regulation while SUT has not previously been reported in the regulation of energy balance. As PYY(3-36) and Ex4 act on different neurons leading to recruitment of different signalling pathways within and to the brain, an interaction of these pathways may contribute to their additive/synergistic action. Thus, PYY(3-36) boosts the effect of Ex4 possibly by inducing less inhibition of neuronal activity leading to an enhanced neuronal activity induced by Ex4.

AB - Peptide YY(3-36) ((PYY(3-36)) and glucagon like peptide 1 (GLP-1) in combination reduce food intake and body weight in an additive or synergistic manner in animal models and in humans. Nevertheless, the mechanisms behind are not completely understood. The present study aims to investigate the effect of combining PYY(3-36) and the GLP-1 receptor agonist exendin-4 (Ex4) by examining acute food intake and global neuronal activation as measured by c-fos in C57BL/6 J mice. An additive reduction in food intake was found 1.5 h after s.c dosing with the combination of PYY(3-36) (200 μg/kg) and Ex4 (2.5 μg/kg). This was associated with a synergistic enhancement of c-fos reactivity in central amygdalar nucleus (CeA), rostral part of the mediobasal arcuate nucleus (ARH), supratrigeminal nucleus (SUT), lateral parabrachial nucleus (PB), area postrema (AP) and nucleus tractus solitarius (NTS) compared to vehicle, PYY(3-36) and Ex4 individually dosed mice. The regions activated by Ex4 individually and PYY(3-36) and Ex4 in combination resembled each other, but the combination group had a significantly stronger c-fos response. Twenty-five brain areas were activated by PYY(3-36) and Ex4 in combination compared to vehicle versus nine brain areas by Ex4 individually. No significant increase in c-fos reactivity was found by PYY(3-36) compared to vehicle dosed mice. The neuronal activation of ARH and the AP/NTS to PB to CeA pathway is important for appetite regulation while SUT has not previously been reported in the regulation of energy balance. As PYY(3-36) and Ex4 act on different neurons leading to recruitment of different signalling pathways within and to the brain, an interaction of these pathways may contribute to their additive/synergistic action. Thus, PYY(3-36) boosts the effect of Ex4 possibly by inducing less inhibition of neuronal activity leading to an enhanced neuronal activity induced by Ex4.

KW - Amygdala/drug effects

KW - Animals

KW - Body Weight/drug effects

KW - Eating/drug effects

KW - Exenatide/pharmacology

KW - Hypothalamus/drug effects

KW - Mice

KW - Neurons/drug effects

KW - Peptide Fragments/pharmacology

KW - Peptide YY/pharmacology

KW - Proto-Oncogene Proteins c-fos/metabolism

U2 - 10.1016/j.npep.2018.11.004

DO - 10.1016/j.npep.2018.11.004

M3 - Journal article

VL - 73

SP - 89

EP - 95

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

ER -

ID: 56926907